Neuroleptic malignant syndrome (NMS) is usually a serious neurologic side effect of antipsychotic therapy and characterized by fever, altered mental state, muscular rigidity, and dysautonomia. This chapter provides a contemporary account of NMS, a synthesis of a voluminous and perplexing literature on its pathobiology and management, and gives clear guidelines on the care and prognosis thereafter for patients who develop NMS.
CITATION STYLE
Mehndiratta, P., Spolter, Y., Igboeli, B., Sajatovic, M., & Buckley, P. F. (2014). Neuroleptic malignant syndrome. In Neuromuscular Disorders in Clinical Practice (Vol. 9781461465676, pp. 1487–1500). Springer New York. https://doi.org/10.1007/978-1-4614-6567-6_74
Mendeley helps you to discover research relevant for your work.